Skip to main content
. 2000 Jun;38(6):2065–2075. doi: 10.1128/jcm.38.6.2065-2075.2000

TABLE 1.

Characteristics of EAV-specific MAbs

MAba Isotype IgG concn (μg/ml) ELISA ODb Antibody titerc Protein specificity Neutralization (titer)d
E1/A19 2a 3 2.6 (0.21) 40 N
E1/b5 1 20 3.3 (0.18) 80 N
E1/c4 1 5 2.0 (0.19) 20 N
E3/a9 1 5 3.2 (0.18) 20 N
E3/a61 1 9 3.2 (0.24) 20 N
E3/c16 2a 42 1.9 (0.32) 40 GL
E3/d10 2b 30 1.4 (0.31) 10 GL
E3/d17 2b 9 3.3 (0.21) 20 N
E3/d52 2b 12 2.4 (0.22) 20 N
E6/A3 2a 22 0.6 (0.21) 3 GL? +(80)
E6/A7 1 85 2.6 (0.21) 160 N
E6/a27 1 5 1.8 (0.18) 10 N
E6/B8 1 12 1.0 (0.28) 10 GL
E6/d24 1 4 2.8 (0.17) 40 N
E7/d15-c1 2b 50 1.2 (0.32) 20 GL +(40)
E7/d15-c9 2a 42 1.7 (0.71) 40 GL +(5)
a

Hybridoma culture supernatant. 

b

OD reading for EAV-infected (mock-infected) Vero cells that were fixed to the ELISA plate. 

c

By IPMA as the reciprocal of the highest dilution of the culture supernatant at which specific cytoplasmic reactivity was clearly observed. 

d

Reciprocal of the highest dilution of the culture supernatant that completely inhibited the CPE of 100 TCID50s of EAV.